JenaValve Technology Inc is a global medical device company based in Irvine, CA. They are dedicated to developing innovative medical device technology that addresses the needs of patients with structural heart disease, particularly those with severe aortic regurgitation. Their flagship product, the Trilogy System, is the only transcatheter aortic valve replacement (TAVR) solution specifically designed for severe aortic regurgitation. JenaValve is committed to supporting physicians and advancing the detection, diagnosis, and treatment of aortic regurgitation through clinical trials, partnerships, and educational events.
Generated from the website